Cefalexin/Trimethoprim

头孢氨苄/甲氧苄啶

Report date: 2023/02/13 17:54:04
NME

Base Information

Drug NameCefalexin/Trimethoprim
Drug Alias Name头孢氨苄甲氧苄啶
ClassificationSmall molecules
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsDihydrofolate reductase inhibitors
TargetsBacterial penicillin-binding proteinDihydrofolate reductase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1993/01/01
Country/TerritoryMainland China
CombinationsYes CefalexinTrimethoprim
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHunan Zhonghe Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01
Related LinksN/A